A multidisciplinary research capability improvement project in Chinese medicine based on the research field of key research office--Research on machine learning to mine the medication patterns of Chinese medicine

The Affiliated Hospital of Liaoning University of Traditional Chinese Medicine0 个研究点开始时间: 待定最近更新: 2023年10月16日

适应症

试验速览

暂无简介。

•1. Patients with valvular heart disease, various types of cardiomyopathy, malignant arrhythmia, and NYHA functional classification III-IV heart failure;
•2. Patients diagnosed with severe brain tumors or traumatic brain diseases;
•3. Patients with acute cerebrovascular disease that occurred in the past 2 weeks, severe pulmonary dysfunction (PaO2 <60mmHg), severe primary diseases of the endocrine and hematopoietic system (aplastic anemia, leukemia, leukopenia and neutropenia, malignant lymphoma Primary immune thrombocytopenia (idiopathic thrombocytopenic purpura), thrombotic thrombocytopenic purpura, primary polycythemia vera, bone marrow abnormal proliferation syndrome, primary myelofibrosis, multiple myeloma, pituitary tumor, diabetes, prolactinoma, thyroid crisis, primary adrenal insufficiency (Addison's disease), Cushing's syndrome, insulinoma), moderate to severe hepatic dysfunction (transaminase levels exceeding the upper limit of normal 3 times) or renal dysfunction (eGFR less than 60/min/1.73m2), and high creatinine levels exceeding the normal value;
•4. History of infection, fever, trauma, burns, or surgery in the past month;
•5. Patients with poor compliance and difficult to follow-up;
•6. Patients with severe visual or auditory impairment, serious cognitive communication impairment, and a history of mental illness;
•7. Patients with untreated or uncontrolled hypertension (BP=180/100mmHg).

发起方

The Affiliated Hospital of Liaoning University of Traditional Chinese Medicine